Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults

NCT03983980 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT03983980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03983980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
June 6, 2019
Completion date
May 29, 2020
Enrollment
515 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis